Nyxoah (NYXH) Competitors $6.52 +0.72 (+12.41%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$6.54 +0.02 (+0.29%) As of 04:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. CLPT, SIBN, BVS, AVNS, ZIMV, BFLY, KIDS, TMCI, SMLR, and CBLLShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include ClearPoint Neuro (CLPT), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), and CeriBell (CBLL). These companies are all part of the "medical equipment" industry. Nyxoah vs. Its Competitors ClearPoint Neuro SiBone Bioventus AVANOS MEDICAL ZimVie Butterfly Network OrthoPediatrics Treace Medical Concepts Semler Scientific CeriBell Nyxoah (NASDAQ:NYXH) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk. Is NYXH or CLPT more profitable? ClearPoint Neuro has a net margin of -66.15% compared to Nyxoah's net margin of -1,541.84%. Nyxoah's return on equity of -79.18% beat ClearPoint Neuro's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,541.84% -79.18% -54.92% ClearPoint Neuro -66.15%-94.44%-51.58% Which has more risk and volatility, NYXH or CLPT? Nyxoah has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Do institutionals & insiders have more ownership in NYXH or CLPT? 30.1% of ClearPoint Neuro shares are held by institutional investors. 6.1% of ClearPoint Neuro shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor NYXH or CLPT? In the previous week, Nyxoah and Nyxoah both had 4 articles in the media. Nyxoah's average media sentiment score of 0.43 beat ClearPoint Neuro's score of 0.32 indicating that Nyxoah is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ClearPoint Neuro 0 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend NYXH or CLPT? Nyxoah presently has a consensus target price of $15.00, indicating a potential upside of 130.06%. ClearPoint Neuro has a consensus target price of $19.67, indicating a potential downside of 25.48%. Given Nyxoah's higher probable upside, analysts clearly believe Nyxoah is more favorable than ClearPoint Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50ClearPoint Neuro 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has stronger valuation and earnings, NYXH or CLPT? ClearPoint Neuro has higher revenue and earnings than Nyxoah. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.89M45.41-$64.10M-$2.30-2.83ClearPoint Neuro$31.39M23.90-$18.91M-$0.81-32.58 SummaryClearPoint Neuro beats Nyxoah on 7 of the 13 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$197.55M$2.26B$6.11B$10.65BDividend YieldN/AN/A5.70%4.74%P/E Ratio-2.8337.1985.6726.85Price / Sales45.4112.34623.73135.13Price / CashN/A61.3337.7861.77Price / Book1.8112.7713.246.70Net Income-$64.10M-$63.46M$3.30B$276.44M7 Day Performance31.98%3.26%3.91%2.48%1 Month Performance11.64%4.60%8.37%8.79%1 Year Performance-30.19%43.78%88.78%34.41% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.6054 of 5 stars$6.52+12.4%$15.00+130.1%-29.9%$197.55M$4.89M-2.83110Gap UpHigh Trading VolumeCLPTClearPoint Neuro0.6857 of 5 stars$21.57+0.1%$19.67-8.8%+144.4%$612.61M$31.39M-26.63110SIBNSiBone3.9816 of 5 stars$14.17+0.9%$23.67+67.0%+15.8%$606.13M$167.18M-25.30350Positive NewsBVSBioventusN/A$6.62-0.6%N/AN/A$550.64M$573.28M13.321,200AVNSAVANOS MEDICAL2.111 of 5 stars$11.55-1.9%N/A-49.9%$546.16M$687.80M-1.152,227Positive NewsZIMVZimVie1.3971 of 5 stars$18.90-0.1%$17.75-6.1%+22.6%$533.47M$443.40M-27.001,770BFLYButterfly Network2.8343 of 5 stars$1.96-2.7%$3.00+53.5%+34.3%$506M$82.06M-6.98460Options VolumeGap UpKIDSOrthoPediatrics4.6292 of 5 stars$18.31+0.2%$34.14+86.5%-26.8%$458.35M$204.73M-10.23200Positive NewsTMCITreace Medical Concepts2.3453 of 5 stars$6.72+0.9%$9.83+46.3%+14.5%$420.73M$209.36M-8.51250Gap UpSMLRSemler Scientific3.2998 of 5 stars$29.24+3.3%$74.25+153.9%+11.8%$419.12M$56.29M12.03120CBLLCeriBell2.6233 of 5 stars$11.50+1.1%$32.14+179.5%N/A$416.87M$65.44M-3.85N/ANews CoveragePositive NewsInsider Trade Related Companies and Tools Related Companies ClearPoint Neuro Competitors SiBone Competitors Bioventus Competitors AVANOS MEDICAL Competitors ZimVie Competitors Butterfly Network Competitors OrthoPediatrics Competitors Treace Medical Concepts Competitors Semler Scientific Competitors CeriBell Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
